Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
NEGXF On Other Exchanges
All times are local (Market data is delayed by at least 15 minutes).

nexgenrx inc (NEGXF) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEXGENRX INC (NEGXF)

Related News

No related news articles were found.

nexgenrx inc (NEGXF) Related Businessweek News

No Related Businessweek News Found

nexgenrx inc (NEGXF) Details

NexgenRx Inc. provides health claims adjudication and related services in Canada. The company administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers. It offers prescription drug claims adjudication; dental claims adjudication; and claims adjudication for extended health benefits, including paramedical services comprising chiropractors, podiatrists, and massage therapists, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; emergency out of province/country travel benefits; collection and payment of premiums for life and LTD coverage; Web claims submission services; retrospective and prospective claims data analysis; and medical concierge services. It offers its benefits to plan sponsors, brokers, consultants, and third party administrators. The company was founded in 2003 and is headquartered in Toronto, Canada.

Founded in 2003

nexgenrx inc (NEGXF) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$165.0K
Interim Chief Financial Officer
Total Annual Compensation: C$118.7K
National Vice President of Sales
Total Annual Compensation: C$200.0K
Compensation as of Fiscal Year 2014.

nexgenrx inc (NEGXF) Key Developments

NexgenRx, Inc. Announces Earnings Results for the Second Quarter and Cash-Flow Results for the First Six Months Ended June 30, 2015

NexgenRx, Inc. announced earnings results for the second quarter and cash-flow results for the first six months ended June 30, 2015. For the quarter, transaction and administration revenue was $1,171,611. Net income was $109,306. For the first six months of 2015, the company generated positive operating cash-flow of $211,867.

NexgenRx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for the Second, Third Quarter and Full Year 2015

NexgenRx, Inc. reported earnings results for the first quarter ended March 31, 2015. For the first quarter ended March 31, 2015 transaction and administration revenue was $1,201,317, generating a net income of $4,560. The company generated an increase in first quarter revenue of 16% compared to the same period in 2014. The company expects 2015 profitable results along with confirmed new sales for second quarter and third quarter of 2015.

NexgenRx, Inc. Announces Earnings Results for the Year Ended December 31, 2014

NexgenRx, Inc. announced earnings results for the year ended December 31, 2014. Revenue for the year ended December 31, 2014 was $4,216,404. The net loss for the year was $477,616 resulting in negative $0.01 per common share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEGXF:US $0.00 USD 0.00

NEGXF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEGXF.
View Industry Companies

Industry Analysis


Industry Average

Valuation NEGXF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 38.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXGENRX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at